Skip to content

The seroprevalence of neutralizing antibody against Dengue virus in health care workers

The seroprevalence of neutralizing antibody against Dengue virus in health care workers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20160303002
Enrollment
402
Registered
2016-03-03
Start date
2015-11-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue fever risk Dengue PRNT Neutralizing antibody Seroprevalence Seroepidemiology Serological study Bangkok adults healthcare workers Thailand

Interventions

Sponsors

Sanofi Pasteur, Thailand
Lead Sponsor
Queen Sirikit National Institute of Child Health
Collaborator

Eligibility

Sex/Gender
All
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: Medical personnel who underwent a medical examination in the year 2015 at Queen Sirikit National Institute of Child Health, and voluntarily join the study

Exclusion criteria

Exclusion criteria: Who did not provided informed consent to a blood test

Design outcomes

Primary

MeasureTime frame
proportion of protective DF antibody Upon enrollment Plaque reduction neutralization test for Dengue fever

Secondary

MeasureTime frame
Predictors of protective antibibody Upon enrollment age, residencial area

Countries

Thailand

Contacts

Public ContactWarunee Vandepitte

QSNICH

waruneep@gmail.com+66-85-515-8299

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026